madman
Super Moderator
“No cancer patient ever got healthier because their claim was denied and delayed. None. Not one.” Mark Cuban's verdict will ring true for any urologist who has fought a denied or delayed claim, and his alternative is a contract that starts by trusting the doctor. On this episode of BackTable Urology, Dr. Ruchika Talwar, urologic oncologist and value-based care leader, talks with Mark Cuban, entrepreneur and founder of Mark Cuban Cost Plus Drug Company, about who actually sets the price of care in the United States. They trace how a cold email about drug shortages led to Cost Plus Drugs and then Cost Plus Wellness, an open source library of direct contracts between self-insured employers and providers, and why he believes the contract, not the published price, is where the real problems hide. By his estimate, 67% of people with job-based coverage get it through a self-insured employer, which makes employers, not insurers, the real payers in American healthcare.
Timestamps
00:00 - Introduction
01:53 - From Drug Shortages to Cost Plus Drugs
06:08 - Cost Plus Wellness and Direct Contracts
11:04 - Publishing Provider Contracts
16:39 - Using AI to Review Contracts and RFPs
20:16 - Direct Contracting Advice for Hospitals and Physicians
26:33 - Value-Based Care, Brokers, and Self-Insured Hospitals
32:09 - Direct Contracting for Independent Practices
34:20 - AI as a Business Adviser for Physicians
38:39 - National Policy and Who Pays for Healthcare
46:59 - Misaligned Incentives and Corporate Culture
51:00 - Key Takeaways
54:04 - Closing Remarks